https://www.avient.com/sites/default/files/2022-11/Packaging Anti-fog Whitepaper.pdf
Whether
a surface coating or an additive concentrate is
selected, the anti-fogging system balances the
differences in surface energies by increasing that
of the film to meet that of the water.
https://www.avient.com/industries/packaging/food-packaging/condiments
Barrier thermoform sheet for Form-Fill-Seal (FFS) applications
Corrugated Sheet
Extrusion Sheet & Strap
https://www.avient.com/industries/packaging/food-packaging/shelf-stable-food
Barrier thermoform sheet for Form-Fill-Seal (FFS) applications
Corrugated Sheet
Extrusion Sheet & Strap
https://www.avient.com/sites/default/files/2020-03/2020proxy.pdf
EXECUTIVE COMPENSATION
Exercise or Base Price of Option Awards (column (i))
Grant Date Fair Value of Stock and Option Awards (column (j))
Narrative Disclosure Relating to the 2019 Summary Compensation Table and the 2019 Grants
of Plan-Based Awards Table
EXECUTIVE COMPENSATION
Outstanding Equity Awards at 2019 Fiscal Year-End
Option
Exercise
Price
($)
(e)
Option
Expiration
Date
(f)
Market
Value of
Shares or
Units of
Stock That
Have Not
Vested
($)
(h)
Equity Incentive
Plan Awards:
Market or Payout
Value of Unearned
Shares, Units or
Other Rights that
Have Not Vested
($)
(j)
Name
(a)
Stock Awards
Equity Incentive
Plan Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options
(#)
(d)
Equity Incentive
Plan Awards:
Number of
Unearned Shares,
Units or Other
Rights that Have
Not Vested
(#)
(i)
Number of
Shares or
Units of Stock
That Have Not
Vested
(#)
(g)
Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
(c)
Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
(b)
Option Awardsp
( ) ( ) (j)( )( )( ) (g)( )( )( )
EXECUTIVE COMPENSATION
Number of Securities Underlying Unexercised Options (#) Exercisable (column (b))
Number of Securities Underlying Unexercised Options (#) Unexercisable (column (c))
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (column (d))
Option Exercise Price (column (e))
EXECUTIVE COMPENSATION
Option Expiration Date (column (f))
Number of Shares or Units of Stock That Have Not Vested (column (g))
Market Value of Shares or Units of Stock That Have Not Vested (column (h))
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested
(column (i))
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have
Not Vested (column (j))
2019 Option Exercises and Stock Vested
Name
(a)
Option Awards Stock Awards
Number of Shares
Acquired on Exercise
(#)
(b)
Value Realized on
Exercise
($)
(c)
Number of Shares
Acquired on Vesting
(#)
(d)
Value Realized
on Vesting
($)
(e)
Stock Awards (columns (d) and (e))
EXECUTIVE COMPENSATION
2019 Nonqualified Deferred Compensation
Name
Aggregate Executive Registrant Aggregate Aggregate Aggregate
Balance at Contributions Contributions Earnings Withdrawals/ Balance at
12/31/2018 in Last FY in Last FY in Last FY Distributions Last FYE
($)(1) ($)(2) ($)(3) ($)(4) ($) ($)(1)(5)
EXECUTIVE COMPENSATION
Potential Payments Upon Termination or Change of Control
Summary of Potential Payments
Management Continuity Agreements
EXECUTIVE COMPENSATION
Executive Severance Plan
Long-Term Incentive Awards
Retirement Benefits
EXECUTIVE COMPENSATION
Payments and Benefits Upon Termination — As of the End of Fiscal Year 2019
Name Benefits and Payments
Voluntary
Termination
($)
Retirement (1) t
($) Disabilitytt ($)
Death
($)
Involuntary
Termination
with Cause
($)
Involuntary
Termination
without
Cause
($)
vo u ta yvo u ta y
Termination
without
Cause or for
Good Reason
Following a
Change of
Control
($)( )( )( )( )y ( )( )( )y
EXECUTIVE COMPENSATION
CEO Pay Ratio Disclosure
CEO Annual Total Compensation for 2019: $6,106,632
Median Employee Annual Total Compensation for 2019: $53,371
Ratio of CEO to Median Employee Annual Total Compensation for 2019: 114:1
How the Median Employee was Determined in 2017
EXECUTIVE COMPENSATION
Compensation Committee Interlocks and Insider Participation
Risk Assessment of the Compensation Programs
Compensation Committee Report
The Compensation Committee
of the Board of Directors
MISCELLANEOUS
MISCELLANEOUS PROVISIONS
Voting at the Meeting
nott
Shareholder Proposals
MISCELLANEOUS
Proxy Solicitation
We will furnish without charge to each person from whom a proxy is being solicited, upon written
request of any such person, a copy of the Annual Report on Form 10-K of the Company for the fiscal year
ended December 31, 2019, as filed with the SEC, including the financial statements and schedules thereto.
https://www.avient.com/sites/default/files/2024-12/AVNT Investor Day 2024 Presentation.pdf
making the whole
to be greater than
the sum of parts
driving disciplined
processes to execute
and deliver results
5
balancing
the microscope
and the telescope
Copyright © .
All Rights Reserved
2024 61
History of balanced capital deployment
$0
.1
6
$0
.2
0 $0
.2
6 $0
.3
4 $
0.
42
$0
.5
0 $
0.
58
$0
.7
2 $0
.7
9
$0
.8
2 $0
.8
8 $0
.9
6
$1
.0
0
$1
.0
3
$1
.0
8
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend
$ per shareAdj.
https://www.avient.com/sites/default/files/resources/PolyOne%25202017%2520Proxy%2520Statement.PDF
● Strong balance sheet and freff e cash flow, as total cash
and liquidity ended the year at $227 million and
$613 million, respectively.
The Board believes that this approach serves to strike an effective balance between
management and independent Director participation in the board process.
The Compensation Committee and management annually review and consider tally sheets, which are developed
by our Human Resources department to provide greater context for the compensation of our Named Executive
Offiff cers.
https://www.avient.com/sites/default/files/resources/Terms_and_Conditions_of_Sale_for_Finland_%2528English_Language_Version%2529.pdf
SAFETY & HEALTH INDEMNITY
Buyer acknowledges that Seller has furnished to Buyer Material Safety Data
Sheets as required under applicable laws and regulations, which include
warnings together with safety and health information concerning the Product
and/or the containers for such Product.
https://www.avient.com/sites/default/files/2023-01/Hydrocerol Chemical Foaming Agents for Injection Molding Technical Bulletin.pdf
The activation of Hydrocerol Chemical Foaming
Agents should happen approximately in the middle
of the barrel exceeding the temperature indicated in
the technical data sheet of the processed Hydrocerol
concentrates grade.
https://www.avient.com/products/thermoplastic-elastomers/versaflex-thermoplastic-elastomers
Safety Data Sheets
Technical Data Sheets
GLS™ Versaflex™ Thermoplastic Elastomer provided the right balance of haptics and fulfilled healthcare regulations
https://www.avient.com/industries/packaging/beverage-packaging/sports-and-energy
Corrugated Sheet
Extrusion Sheet & Strap
GLS™ Versaflex™ Thermoplastic Elastomer provided the right balance of haptics and fulfilled healthcare regulations